Drug class in one race
Aromatase drugs for HR+/HER2- Metastatic Breast Cancer
3 tracked Aromatase drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the Aromatase page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
3 approved / phase 4
Head-to-head evidence: Anastrozole vs Exemestane · Anastrozole vs Letrozole · Exemestane vs Letrozole